Florida’s monoclonal antibody sites close due to FDA order; DeSantis calls it ‘reckless decision’

Jacksonville, FL — Monoclonal antibody sites statewide abruptly closed late Monday after the U.S. Food and Drug Administration decided to remove the emergency use authorizations for two monoclonal antibody treatments.

RELATED: FDA orders monoclonal antibody treatments to stop

The revised authorizations do not allow providers to administer bamlanivimab/etesevimab and REGEN-COV in the United States.

That means monoclonal treatment sites all over Florida will be closed until further notice.

In a news release, the Florida Department of Health said it disagreed with the FDA’s decision.

It said the decision was made in the absence of clinical evidence.

STORY: Texas brothers, friend beat stepfather to death for sexually abusing sister, police say

Florida Gov. Ron DeSantis expressed his opposition to the FDA’s decision on Tuesday morning as well, calling it a “reckless decision to take this option away from patients.”

“This is really a sudden shift and I think it caught a lot of people by surprise,” DeSantis said.

STORY: Florida senator fights back over nude images stolen from her

DeSantis vowed to fight back against the federal government, saying that even if the treatment is only half or 25% as effective against omicron, it is better than nothing.

If you had an appointment for monoclonal antibody treatment, you will be contacted about cancellations.

STORY: IRS says Child Tax Credit letter 6419 may not be accurate

If you have tested positive for COVID-19, please contact your health provider.

And for more information about why this decision was made, please contact the FDA at 1-888-463-6332.